We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
-6.03%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$327M
AUM Growth
+$19.5M
Cap. Flow
+$40.6M
Cap. Flow %
12.42%
Top 10 Hldgs %
98.06%
Holding
29
New
5
Increased
2
Reduced
1
Closed
16

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$27.3M
2
AKYA
Akoya BioSciences
AKYA
+$22.4M
3
NTRA icon
Natera
NTRA
+$17.5M
4
AVTR icon
Avantor
AVTR
+$16.2M
5
DHR icon
Danaher
DHR
+$9.76M

Top Sells

Rank Stock Value
1
RVTY icon
Revvity
RVTY
+$19.6M
2
TWST icon
Twist Bioscience
TWST
+$13.4M
3
NEO icon
NeoGenomics
NEO
+$10.7M
4
CDNA icon
CareDx
CDNA
+$3.94M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$815K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Communication Services 0%
3 Consumer Discretionary 0%
4 Energy 0%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTRA icon
1
Natera
NTRA
$46.9B
$67.4M 20.63%
722,181
+168,800
+31% +$17.5M
TMO icon
2
Thermo Fisher Scientific
TMO
$227B
$52.2M 15.98%
78,300
– –
GH icon
3
Guardant Health
GH
$21.9B
$39.1M 11.96%
390,945
+264,121
+208% +$27.3M
CDNA icon
4
CareDx
CDNA
$2.41B
$38.4M 11.76%
844,970
-75,521
-8% -$3.94M
TECH icon
5
Bio-Techne
TECH
$11.3B
$28.3M 8.66%
218,844
– –
A icon
6
Agilent Technologies
A
$43.9B
$26.8M 8.21%
168,150
– –
AKYA
7
DELISTED
Akoya BioSciences
AKYA
$26.2M 8.01%
+1,710,807
New +$22.4M
AVTR icon
8
Avantor
AVTR
$9.44B
$17.3M 5.29%
+410,270
New +$16.2M
DNA icon
9
Ginkgo Bioworks
DNA
$519M
$14.4M 4.4%
43,245
– –
DHR icon
10
Danaher
DHR
$149B
$10.3M 3.16%
+35,419
New +$9.76M
SLGC
11
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$4.67M 1.43%
400,988
– –
PEAR
12
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$1.21M 0.37%
+194,686
New +$1.74M
BTTX
13
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$465K 0.14%
+100,000
New +$820K
AAPL icon
14
Apple
AAPL
$4.62T
– –
-4,000
Closed -$566K
ADBE icon
15
Adobe
ADBE
$108B
– –
-1,094
Closed -$630K
AMZN icon
16
Amazon
AMZN
$2.87T
– –
-4,000
Closed -$657K
CVX icon
17
Chevron
CVX
$404B
– –
-4,420
Closed -$448K
GOOGL icon
18
Alphabet (Google) Class A
GOOGL
$4.22T
– –
-6,100
Closed -$815K
GS icon
19
Goldman Sachs
GS
$297B
– –
-833
Closed -$315K
ISRG icon
20
Intuitive Surgical
ISRG
$141B
– –
-1,320
Closed -$437K
JPM icon
21
JPMorgan Chase
JPM
$950B
– –
-13,762
Closed -$616K
MSFT icon
22
Microsoft
MSFT
$3.6T
– –
-2,726
Closed -$769K
NEO icon
23
NeoGenomics
NEO
$2.14B
– –
-222,222
Closed -$10.7M
NVDA icon
24
NVIDIA
NVDA
$5.27T
– –
-36,280
Closed -$752K
PHYS icon
25
Sprott Physical Gold
PHYS
$16.2B
– –
-45,626
Closed -$630K
1
2

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Blue Water Life Science Advisors held 29 positions worth $327M, up 6.3% from $307M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Blue Water Life Science Advisors deployed $40.6M of net new capital in Q4 2021, opening 5 new positions and adding to 2 existing holdings. Its largest new stake was Akoya BioSciences: 1,710,807 shares worth $26.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 98% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was CareDx, an estimated $3.94M trimmed.

  • Blue Water Life Science Advisors's largest Q4 2021 buy was Akoya BioSciences: 1,710,807 shares worth $26.2M.
  • Blue Water Life Science Advisors added most to Guardant Health in Q4 2021, an estimated $27.3M increase.
  • Blue Water Life Science Advisors's biggest Q4 2021 reduction was CareDx, cutting an estimated $3.94M.
  • Blue Water Life Science Advisors fully exited Revvity in Q4 2021, selling an estimated $19.6M.
  • Blue Water Life Science Advisors's ten largest holdings make up 98% of its $327M portfolio in Q4 2021.
  • Blue Water Life Science Advisors opened 5 new positions and closed 16 in Q4 2021.
  • Blue Water Life Science Advisors's portfolio value rose 6.3% quarter-over-quarter to $327M.

Based on Blue Water Life Science Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.